Identification of d-Galactan-III As Part of the Lipopolysaccharide of Klebsiella pneumoniae Serotype O1
is a Gram-negative, ubiquitous bacterium capable of causing severe nosocomial infections in individuals with impaired immune system. Emerging multi-drug resistant strains of this species and particularly carbapenem-resistant strains pose an urgent threat to public health. The lipopolysaccharide (LPS...
Saved in:
Published in | Frontiers in microbiology Vol. 8; p. 684 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
25.04.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | is a Gram-negative, ubiquitous bacterium capable of causing severe nosocomial infections in individuals with impaired immune system. Emerging multi-drug resistant strains of this species and particularly carbapenem-resistant strains pose an urgent threat to public health. The lipopolysaccharide (LPS) O-antigen is the main surface antigen. It contributes to the virulence of this species and determines the O-serotype of
isolates. Among the nine main O-serotypes of
, O1-and O2-type pathogens are causative agents of over 50% of all infections. Serotype O1, the most common O-serotype, expresses complex LPS consisting of d-galactan-I (a polymer built of → 3)-β-d-Gal
-(1 → 3)-α-d-Gal
-(1 → repeating units) capped by d-galactan-II (built of [ → 3)-α-d-Gal
-(1 → 3)-β-d-Gal
-(1 →] repeating units). Galactan-I is present as the sole polymer in O2 serotype. Recently, in case of serotype O2, conversion of galactan-I to galactan-III (→ 3)-β-d-Gal
-(1 → 3)-[α-d-Gal
-(1 → 4)]-α-d-Gal
-(1 →) was reported. Substitution of → 3)-α-d-Gal
by a branching terminal α-d-Gal
was dependent on the presence of the
operon and had a major impact on the antigenicity of the galactan polymer. Genetic analysis indicated that 40% of the O1 clinical isolates also carry the
locus; therefore we aimed to characterize the corresponding phenotype of LPS O-antigens. The presence of galactan-III among O1 strains was proven using galactan-III-specific monoclonal antibodies and confirmed by structural analyses performed using sugar and methylation analysis as well as classical and high-resolution magic angle spinning NMR spectroscopy. By using an isogenic mutant pair, we demonstrated that galactan-III expression was dependent on the presence of glycosyltransferases encoded by
, as was shown previously for the O2 serotype. Furthermore, the galactan-II structures in O1
+ strains remained unaffected corroborating no functional interactions between the biosynthesis of galactan-III and galactan-II polymers. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Dongsheng Zhou, Beijing Institute of Microbiology and Epidemiology, China Reviewed by: Nikolay Nifantiev, N.D. Zelinsky Institute of Organic Chemistry (RAS), Russia; Marta Palusinska-Szysz, Maria Curie-Skłodowska University, Poland This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology |
ISSN: | 1664-302X 1664-302X |
DOI: | 10.3389/fmicb.2017.00684 |